These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 16178882)
41. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. Valsamakis G; Anwar A; Tomlinson JW; Shackleton CH; McTernan PG; Chetty R; Wood PJ; Banerjee AK; Holder G; Barnett AH; Stewart PM; Kumar S J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090 [TBL] [Abstract][Full Text] [Related]
42. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276 [TBL] [Abstract][Full Text] [Related]
43. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver. Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719 [TBL] [Abstract][Full Text] [Related]
44. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837 [TBL] [Abstract][Full Text] [Related]
45. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237 [TBL] [Abstract][Full Text] [Related]
46. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome. Loerz C; Maser E J Steroid Biochem Mol Biol; 2017 Nov; 174():65-71. PubMed ID: 28765040 [TBL] [Abstract][Full Text] [Related]
47. The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps. Jiang L; Zhou M; Deng J; Sun Y; Zuo K; Zheng R; Shi J; Lai Y Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):131-137. PubMed ID: 30446829 [TBL] [Abstract][Full Text] [Related]
48. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269 [TBL] [Abstract][Full Text] [Related]
49. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts. Sun K; Myatt L Endocrinology; 2003 Dec; 144(12):5568-77. PubMed ID: 12960005 [TBL] [Abstract][Full Text] [Related]
50. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites. Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772 [TBL] [Abstract][Full Text] [Related]
51. Application of ELISA Technique and Human Microsomes in the Search for 11 Kupczyk D; Studzińska R; Bilski R; Woźniak A Biomed Res Int; 2019; 2019():5747436. PubMed ID: 31214617 [TBL] [Abstract][Full Text] [Related]
52. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Whorwood CB; Donovan SJ; Wood PJ; Phillips DI J Clin Endocrinol Metab; 2001 May; 86(5):2296-308. PubMed ID: 11344242 [TBL] [Abstract][Full Text] [Related]
53. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development. Ge R; Huang Y; Liang G; Li X Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040 [TBL] [Abstract][Full Text] [Related]
54. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target. Tomlinson JW Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012 [TBL] [Abstract][Full Text] [Related]
55. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism. Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233 [TBL] [Abstract][Full Text] [Related]
56. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326 [TBL] [Abstract][Full Text] [Related]
57. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. Andrews RC; Rooyackers O; Walker BR J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867 [TBL] [Abstract][Full Text] [Related]
58. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008 [TBL] [Abstract][Full Text] [Related]
59. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364 [TBL] [Abstract][Full Text] [Related]
60. Distribution of glucocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase isoforms in the rat inner ear. Terakado M; Kumagami H; Takahashi H Hear Res; 2011 Oct; 280(1-2):148-56. PubMed ID: 21669268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]